Suchergebnisse - "Kumar, Deepali"

PubPharm (312)

21

Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion

enthalten in: JTCVS open | 2023

von Ribeiro, R. | Samman, A. | Wang, A. | +7

22

The COVID-19 Pandemic and Adult Cardiac Transplantation : Impact, Interventions, and Implications

enthalten in: The Canadian journal of cardiology | 2023

von Chih, S. | Clarke, B. | Albert, M. | +8

23

Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab

enthalten in: The Lancet. Infectious diseases | 2023

von Solera, J. | Arbol, B. | Ferreira, V. | +12

24

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients : A Prospective Multicenter Canadian Study

enthalten in: Open forum infectious diseases | 2023

von Kabbani, D. | Yotis, D. | Ferreira, V. | +14

25

Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole

enthalten in: Open forum infectious diseases | 2023

von Hall, V. | Tang, K. | Kumar, D. | +5

26

Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2023

von Ferreira, V. | Hu, Q. | Kurtesi, A. | +5

27

Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2023

von Solera, J. | Árbol, B. | Bahinskaya, I. | +3

28

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients : Phase 3 IMAGINE study rationale and design

enthalten in: Trials | 2022

von Nickerson, P. | Böhmig, G. | Chadban, S. | +7

29

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

enthalten in: Trials | 2022

von Nickerson, P. | Böhmig, G. | Chadban, S. | +7

30

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

enthalten in: Trials | 2022

von Nickerson, P. | Böhmig, G. | Chadban, S. | +7